The Enterprise Value as of December 2025 (TTM) for Shield Therapeutics plc (STX.L) is 125.07M

According to Shield Therapeutics plc’s latest financial reports and current stock price. The company's current Enterprise Value is 125.07M. This represents a change of 206.50% compared to the average of 40.81M of the last 4 quarters.

Shield Therapeutics plc (STX.L) Historical Enterprise Value (quarterly & annually)

How has STX.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Shield Therapeutics plc over the last ten years is 84.78M. The current 125.07M Enterprise Value has changed 14.65% with respect to the historical average. Over the past ten years (40 quarters), STX.L's Enterprise Value was at its highest in in the June 2020 quarter at 163.26M. The Enterprise Value was at its lowest in in the June 2016 quarter at -28455000.00.

Shield Therapeutics plc (STX.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Shield Therapeutics plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shield Therapeutics plc (STX.L) Average Enterprise Value

How has STX.L Enterprise Value performed in the past?

The current Enterprise Value of Shield Therapeutics plc (STX.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Shield Therapeutics plc (STX.L) Enterprise Value vs. Peers

How is STX.L’s Enterprise Value compared to its peers?

Shield Therapeutics plc’s Enterprise Value is greater than Venture Life Group plc (100.05M), greater than BATM Advanced Communications Ltd. (86.74M), greater than ECO Animal Health Group plc (50.99M), greater than Ondine Biomedical Inc. (71.33M), greater than INSPECS Group plc (119.37M), greater than Hemogenyx Pharmaceuticals Plc (37.91M), greater than ImmuPharma plc (30.05M), greater than Scancell Holdings plc (102.11M), greater than Creo Medical Limited (24.97M), greater than Chill Brands Group PLC (6.15M),

Build a custom stock screener for Shield Therapeutics plc (STX.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shield Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shield Therapeutics plc (STX.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shield Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.